CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
|
3 Months Ended |
12 Months Ended |
Dec. 31, 2020 |
Dec. 31, 2021 |
| Cash Flows from Operating Activities: |
|
|
| Net income (loss) |
$ (4,891)
|
$ 3,311,639
|
| Adjustments to reconcile net income (loss) to net cash used in operating activities: |
|
|
| Interest earned on marketable securities held in Trust Account |
|
(97,231)
|
| Unrealized gain on marketable securities held in Trust Account |
|
(3,392)
|
| Change in fair value of warrant liabilities |
|
(4,720,125)
|
| Transaction costs allocated to warrant liabilities |
|
675,351
|
| Changes in operating assets and liabilities: |
|
|
| Prepaid expenses |
|
(23,750)
|
| Accrued offering costs |
|
(32,966)
|
| Accrued expenses |
|
211,548
|
| Net cash used in operating activities |
(4,891)
|
(678,926)
|
| Cash Flows from Investing Activities: |
|
|
| Investment of cash into trust Account |
|
(241,500,000)
|
| Net cash used in investing activities |
|
(241,500,000)
|
| Cash Flows from Financing Activities: |
|
|
| Proceeds from initial public offering, net of underwriting discounts paid |
|
236,250,000
|
| Proceeds from sale of Private Placements Units |
|
6,750,000
|
| Proceeds from promissory note - related party |
43,556
|
44,708
|
| Repayment of convertible promissory note - related party |
|
(88,264)
|
| Payment of offering costs |
(37,665)
|
(253,314)
|
| Net cash provided by financing activities |
5,891
|
242,703,130
|
| Net Change in Cash |
1,000
|
524,204
|
| Cash - Beginning |
|
1,000
|
| Cash - Ending |
1,000
|
525,204
|
| Non-cash investing and financing activities: |
|
|
| Offering costs included in accrued offering costs |
17,966
|
|
| Subsequent measurement of Class A ordinary shares to redemption amount |
|
25,216,158
|
| Deferred underwriting fee payable |
|
9,082,500
|
| Initial classification of warrant liabilities |
|
$ 11,422,875
|
| Offering costs paid by Sponsor in exchange for issuance of founder shares |
$ 25,000
|
|